Bassaganya-Riera Josep's Form 4 filing
Landos Biopharma, Inc. (LABP) · filed Dec 20, 2021
- Accession no.
- 0001843575-21-000010
- Filed
- Dec 20, 2021
- Trade date
- Dec 16-20, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $456.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bassaganya-Riera JosepCIK 0001843575 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | common stock | GGiftDisposed | −58,651 | $0.00 | $0 | 5,087,703 | Indirect | |
| Dec 16, 2021 | common stock | SSaleDisposed | −24,301 | $5.11 | −$124,178.11 | 5,063,402 | Indirect | |
| Dec 17, 2021 | common stock | SSaleDisposed | −36,000 | $4.84 | −$174,240 | 5,027,402 | Indirect | |
| Dec 20, 2021 | common stock | SSaleDisposed | −33,194 | $4.75 | −$157,671.5 | 4,994,208 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.